GlobalData CRO invitation
...
Eight drug/drug candidates formulated as aerosols
...
Making hydrophobic compounds “soluble” with customizable release properties
...
Inhaled Losartan in COVID-19 – Interview
...
Digoxin-N preclinical dose escalation
...
Angiotensin Receptor Blockers: Pros and Cons
...
Pharmacokinetics questions
...
PRESS RELEASE
...
Why Losartan?
...
Losartan-N in 48 hours
...
Losartan-N: animal study
...
Why Digoxin?
...
What other drugs?
...